Adnexus Therapeutics

Adnexus Therapeutics Appoints Martin Freed, MD as Chief Medical Officer

Adnexus Therapeutics Appoints Martin Freed, MD as Chief Medical Officer

July 11, 2007

Waltham, MA, July 11, 2007 – Adnexus Therapeutics today announced the expansion of its management team with the appointment of Martin I. Freed, M.D., F.A.C.P. to the newly-created role of Chief Medical Officer. Dr. Freed is an experienced drug developer in several therapeutic areas. He played a key role in the development of Avandia® (rosiglitazone maleate), a drug to treat metabolic disease, including guiding its development from a preclinical compound to the market place, and he also has experience in oncology and inflammation drug development.

Ze-gen, Inc.

Ze-gen, Inc. Secures $4.5 Million in Series A Funding from Flagship Ventures and VantagePoint Venture Partners

Ze-gen, Inc. Secures $4.5 Million in Series A Funding from Flagship Ventures and VantagePoint Venture Partners

July 16, 2007

Adds Seasoned CleanTech Investors to Board of Directors

Mascoma Corporation

Mascoma Corporation Appoints T. Jack Huggins to Board of Directors

Mascoma Corporation Appoints T. Jack Huggins to Board of Directors

July 17, 2007

Brings Expertise in Ethanol, Agribusiness, Agronomy, and Conservation

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mascoma Corporation, a leader in low-carbon cellulosic biomass-to-ethanol production through advanced biotechnology, today announced that T. Jack Huggins has joined the company’s Board of Directors.

Mascoma Corporation

Granholm Says New Ethanol Plant to Put Michigan First in Race to Turn "Wood to Wheels"

Granholm Says New Ethanol Plant to Put Michigan First in Race to Turn "Wood to Wheels"

July 19, 2007

Mascoma to invest here, partner with MSU, Michigan Tech

Ze-gen, Inc.

Ze-gen, Inc. Hosts Ribbon Cutting at Demonstration Facility in New Bedford

Ze-gen, Inc. Hosts Ribbon Cutting at Demonstration Facility in New Bedford

July 24, 2007

Facility will pilot company’s innovative waste gasification and renewable energy generation technology

LS9

Robert Walsh Appointed President of LS9, Inc., the Renewable Petroleum Company™

Robert Walsh Appointed President of LS9, Inc., the Renewable Petroleum Company™

July 30, 2007

Oil industry veteran to direct commercial development of DesignerBiofuels™ Products

SAN CARLOS, CA – July 30, 2007 – LS9, Inc., the Renewable Petroleum Company™, has named Robert Walsh its new President, effective immediately. Walsh will lead the rapid commercialization of LS9 DesignerBiofuels™ products, including a pilot facility leading to commercial production.

LS9

LS9 Wins Presidential Green Chemistry Challenge Award

LS9 Wins Presidential Green Chemistry Challenge Award

June 21, 2010

Renewable Petroleum™ technology efficiently converts renewable raw materials into low-carbon fuels and chemicals

SOUTH SAN FRANCISCO, CA -- June 21, 2010 -- LS9, Inc., the Renewable Petroleum Company™, today announced that it has won the U.S. Environmental Protection Agency’s (EPA) highest environmental honor for its revolutionary Renewable Petroleum™ technology that converts sustainable, plant-based materials into low-carbon fuels and chemicals.

Everyday Solutions, Inc.

Fontinalis Partners Announces Investment in Everyday Solutions the Leading Provider of GPS-Driven School Transportation Information Management Systems

Fontinalis Partners Announces Investment in Everyday Solutions the Leading Provider of GPS-Driven School Transportation Information Management Systems

June 18, 2010

Acton, MA / Detroit, MI USA, Jun. 18, 2010 — Fontinalis Partners, LLC, a Michigan-based strategic investment firm, today announced that it has invested in Everyday Solutions, Inc., the leading provider of GPS-driven school transportation information management systems. Existing investors Ascent Venture Partners and Flagship Ventures also participated. The financial terms of the transaction were not disclosed.

LS9, Creator of Synthetic Microbes to Make Biofuel, Edges Toward Moment of Truth

LS9, Creator of Synthetic Microbes to Make Biofuel, Edges Toward Moment of Truth

June 15, 2010

Every hot startup has to put up or shut up at some point. This is when it’s time to stop talking about the gee-whiz founding idea and scientific progress. It’s the point when a company needs to prove it can operate a disciplined, sustainable business. The moment is fast approaching for LS9.

Ensemble Therapeutics Corporation

Ensemble Discovery and Roche Initiate Research Collaboration to Apply New Diagnostic Technology to Optimize Cancer Therapy

Ensemble Discovery and Roche Initiate Research Collaboration to Apply New Diagnostic Technology to Optimize Cancer Therapy

July 30, 2007

Collaboration will enable analysis of critical drug target family in patient cancer biopsies and selection of appropriate therapy